Will Growing Awareness Regarding Importance of Early Influenza Diagnosis Drive Market Growth As per a new report published by Fact.MR – a market research and competitive intelligence provider, the global influenza diagnostics market is anticipated to top US$ 4 Bn by 2031, and is expected to progress at a CAGR of 5% over the next ten years. Influenza, also known as flu, is an infectious disease caused due to the influenza virus. It affects the upper respiratory tract in humans. Influenza is common in children and the elderly population (aged 65 years and above). Three types of the influenza virus are type A, type B, and type C. For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6682 Increasing prevalence of influenza, emergence of technologically advanced influenza diagnostics, and growth in research funding for influenza diagnostics are expected to drive the market over the predicted years. Demand for RIDT (rapid influenza diagnostic testing) is predicted to be significant over the coming years due to rising adoption of cost-effective and faster RIDT as a first line of diagnosis. Key Takeaways from Market Study
The market for influenza diagnostics to grow 1.6X in value by 2031-end. North America accounts for 37% global revenue share for influenza diagnostics. Increasing prevalence of influenza and growing awareness for early detection using specific diagnostic tests are driving demand for influenza diagnostics. Among the types of tests, rapid diagnostics influenza testing holds the largest revenue share. Demand for RT-PCR tests is expected to expand at a CAGR of 5% over the assessment period.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=6682 Key Segments Covered in Influenza Diagnostics Industry Research By Test
Traditional Influenza Diagnostic Tests Rapid Influenza Diagnostic Tests (RIDTs Direct Fluorescent Antibody (DFA) Tests Viral Culture Serological Assays Molecular Influenza Diagnostic Tests Reverse Transcription Polymerase Chain Reaction (RT-PCR) Isothermal Nucleic Acid Amplification Tests (INAAT) Loop Mediated Isothermal-based Amplification Assays Transcription Mediated Isothermal-based Amplification Assays Transcription Mediated Isothermal-based Amplification Assays
By End User
Influenza Diagnostics at Hospitals & Clinical Laboratories Influenza Diagnostics at Diagnostic Reference Laboratories Influenza Diagnostics at Academic/Research Institutes
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/6682 Winning Strategy The market for influenza diagnostics projects a highly competitive scenario. Major players are focusing on new and advanced product launches that are user friendly and easily available over the counter. Major players are also adopting various growth strategies such as mergers & acquisitions, product expansions, agreements, partnerships, and others to strengthen their position in this market. Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/newsrelease/2020/04/06/2012161/0/en/Atopic-Dermatitis-Market-Valuation-to-Approach-US-19-Bn-by-2027Biologics-Continue-to-Provide-a-Major-Thrust-Finds-a-New-Fact-MR-Study.html About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. Contact: US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 Corporate Headquarter: Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates Email: sales@factmr.com Visit Our Website: https://www.factmr.com